Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Regenerative Medicine Market by Type (Cell Therapy, Tissue Engineering, Biomaterial, Other, Regenerative Medicin), By Application (Dermatology, Cardiovascular, CNS, Orthopedic, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Regenerative Medicine Market by Type (Cell Therapy, Tissue Engineering, Biomaterial, Other, Regenerative Medicin), By Application (Dermatology, Cardiovascular, CNS, Orthopedic, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168173 3300 Medical Devices & Consumables 377 232 Pages 5 (35)
                                          

The global regenerative medicine market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. Cell therapy segment accounted for the largest share in the global regenerative medicine market in 2018 and is expected to continue its dominance throughout the forecast period. Cell therapy segment includes cell-based therapies such as stem cells and mesenchymal stem cells (MSCs). Cell-based therapies are used for various applications such as cardiovascular diseases, neurological disorders, orthopedic disorders, dermatology conditions etc, which are driving this segment’s growth. Tissue engineering segment accounted for the second largest share in 2018 and is expected to grow at a CAGR of 13% during the forecast period due to its use in various applications including wound healing and tissue regeneration. Biomaterials accounted for third largest share in 2018 due to their use in various applications including wound healing and tissue regeneration. Regenerative medicines are used across different application areas such as dermatology conditions, cardiovascular diseases, neurological disorders etc, which are driving this segment’s growth during the forecast period. North America was estimated to account for over 40% of total revenue generated by regenerative medicines globally owing to high prevalence rates of chronic diseases coupled with high healthcare expenditure per capita among other factors; however Asia Pacific region is projected to witness fastest growth rate during 2019-2030 owing mainly due increased awareness about benefits offered by these products coupled with low cost treatments available here compared with other regions like Europe or North America where they have been more expensive treatments available till date.

  1. Increasing prevalence of chronic diseases such as diabetes mellitus type 2 (DM2) and cancer are driving the demand for regenerative medicines globally which in turn is fueling the growth of this market over the forecast period (2017-2025).
  2. Regenerative medicines are also gaining traction due to their ability to treat complex diseases that have no cure or treatment options available currently such as Alzheimer's disease (AD), Parkinson's disease (PD), spinal cord injury (SCI) etc, which will further fuel its growth over the forecast period .

Industry Growth Insights published a new data on “Regenerative Medicine Market”. The research report is titled “Regenerative Medicine Market research by Types (Cell Therapy, Tissue Engineering, Biomaterial, Other, Regenerative Medicin), By Applications (Dermatology, Cardiovascular, CNS, Orthopedic, Others), By Players/Companies DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals, Regenerative Medicin”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Regenerative Medicine Market Research Report

By Type

Cell Therapy, Tissue Engineering, Biomaterial, Other, Regenerative Medicin

By Application

Dermatology, Cardiovascular, CNS, Orthopedic, Others

By Companies

DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals, Regenerative Medicin

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

232

Number of Tables & Figures

163

Customization Available

Yes, the report can be customized as per your need.


Global Regenerative Medicine Industry Outlook


Global Regenerative Medicine Market Report Segments:

The global Regenerative Medicine market is segmented on the basis of:

Types

Cell Therapy, Tissue Engineering, Biomaterial, Other, Regenerative Medicin

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Dermatology, Cardiovascular, CNS, Orthopedic, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. DePuy Synthes
  2. Medtronic
  3. ZimmerBiomet
  4. Stryker
  5. Acelity
  6. MiMedx Group
  7. Organogenesis
  8. UniQure
  9. Cellular Dynamics International
  10. Osiris Therapeutics
  11. Vcanbio
  12. Gamida Cell
  13. Golden Meditech
  14. Cytori
  15. Celgene
  16. Vericel Corporation
  17. Guanhao Biotech
  18. Mesoblast
  19. Stemcell Technologies
  20. Bellicum Pharmaceuticals
  21. Regenerative Medicin

Global Regenerative Medicine Market Overview


Highlights of The Regenerative Medicine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Cell Therapy
    2. Tissue Engineering
    3. Biomaterial
    4. Other
    5. Regenerative Medicin
  1. By Application:

    1. Dermatology
    2. Cardiovascular
    3. CNS
    4. Orthopedic
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Regenerative Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Regenerative Medicine Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Regenerative medicine is a field of medical science that uses techniques to restore or improve the function of damaged cells, tissues, organs and whole bodies.

Some of the key players operating in the regenerative medicine market are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals, Regenerative Medicin.

The regenerative medicine market is expected to register a CAGR of 12.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Regenerative Medicine Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Regenerative Medicine Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Regenerative Medicine Market - Supply Chain
   4.5. Global Regenerative Medicine Market Forecast
      4.5.1. Regenerative Medicine Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Regenerative Medicine Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Regenerative Medicine Market Absolute $ Opportunity

5. Global Regenerative Medicine Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Regenerative Medicine Market Size and Volume Forecast by Type
      5.3.1. Cell Therapy
      5.3.2. Tissue Engineering
      5.3.3. Biomaterial
      5.3.4. Other
      5.3.5. Regenerative Medicin
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Regenerative Medicine Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Regenerative Medicine Market Size and Volume Forecast by Application
      6.3.1. Dermatology
      6.3.2. Cardiovascular
      6.3.3. CNS
      6.3.4. Orthopedic
      6.3.5. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Regenerative Medicine Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Regenerative Medicine Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Regenerative Medicine Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Regenerative Medicine Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Regenerative Medicine Demand Share Forecast, 2019-2026

9. North America Regenerative Medicine Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Regenerative Medicine Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Regenerative Medicine Market Size and Volume Forecast by Application
      9.4.1. Dermatology
      9.4.2. Cardiovascular
      9.4.3. CNS
      9.4.4. Orthopedic
      9.4.5. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Regenerative Medicine Market Size and Volume Forecast by Type
      9.7.1. Cell Therapy
      9.7.2. Tissue Engineering
      9.7.3. Biomaterial
      9.7.4. Other
      9.7.5. Regenerative Medicin
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Regenerative Medicine Demand Share Forecast, 2019-2026

10. Latin America Regenerative Medicine Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Regenerative Medicine Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Regenerative Medicine Market Size and Volume Forecast by Application
      10.4.1. Dermatology
      10.4.2. Cardiovascular
      10.4.3. CNS
      10.4.4. Orthopedic
      10.4.5. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Regenerative Medicine Market Size and Volume Forecast by Type
      10.7.1. Cell Therapy
      10.7.2. Tissue Engineering
      10.7.3. Biomaterial
      10.7.4. Other
      10.7.5. Regenerative Medicin
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Regenerative Medicine Demand Share Forecast, 2019-2026

11. Europe Regenerative Medicine Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Regenerative Medicine Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Regenerative Medicine Market Size and Volume Forecast by Application
      11.4.1. Dermatology
      11.4.2. Cardiovascular
      11.4.3. CNS
      11.4.4. Orthopedic
      11.4.5. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Regenerative Medicine Market Size and Volume Forecast by Type
      11.7.1. Cell Therapy
      11.7.2. Tissue Engineering
      11.7.3. Biomaterial
      11.7.4. Other
      11.7.5. Regenerative Medicin
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Regenerative Medicine Demand Share, 2019-2026

12. Asia Pacific Regenerative Medicine Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Regenerative Medicine Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Regenerative Medicine Market Size and Volume Forecast by Application
      12.4.1. Dermatology
      12.4.2. Cardiovascular
      12.4.3. CNS
      12.4.4. Orthopedic
      12.4.5. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Regenerative Medicine Market Size and Volume Forecast by Type
      12.7.1. Cell Therapy
      12.7.2. Tissue Engineering
      12.7.3. Biomaterial
      12.7.4. Other
      12.7.5. Regenerative Medicin
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Regenerative Medicine Demand Share, 2019-2026

13. Middle East & Africa Regenerative Medicine Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Regenerative Medicine Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Regenerative Medicine Market Size and Volume Forecast by Application
      13.4.1. Dermatology
      13.4.2. Cardiovascular
      13.4.3. CNS
      13.4.4. Orthopedic
      13.4.5. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Regenerative Medicine Market Size and Volume Forecast by Type
      13.7.1. Cell Therapy
      13.7.2. Tissue Engineering
      13.7.3. Biomaterial
      13.7.4. Other
      13.7.5. Regenerative Medicin
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Regenerative Medicine Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Regenerative Medicine Market: Market Share Analysis
   14.2. Regenerative Medicine Distributors and Customers
   14.3. Regenerative Medicine Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. DePuy Synthes
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Medtronic
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. ZimmerBiomet
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Stryker
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Acelity
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. MiMedx Group
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Organogenesis
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. UniQure
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Cellular Dynamics International
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Osiris Therapeutics
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Vcanbio
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Gamida Cell
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Golden Meditech
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Cytori
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Celgene
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Vericel Corporation
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. Guanhao Biotech
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. Mesoblast
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. Stemcell Technologies
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. Bellicum Pharmaceuticals
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us